NaturalShrimp Inc (SHMP)

[fantasytrip]

The system is a success.

The range of success we already know starts at a conservative 2.16 a share if they had numbers equaling biofloc.

But what puts over its success is even if the numbers matched biofloc RAS system, the system itself costs MUCH LESS MONEY to run.

If the shrimp viability does approach 100 percent, the value of the company rises to 3.60 a share.

Either way, it is already a given that an RAS system that has succeeded with electrocoagulation is a more attractive system for large scale output.

It will be so to bigger companies who may want to cut out the middleman and raise their own fish.